Audrey Koitka-Weber

Dr

20082019
If you made any changes in Pure these will be visible here soon.

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2008 2019

Hemodynamic effects of the dipeptidyl peptidase-4 inhibitor linagliptin with renin-angiotensin system inhibitors in type 2 diabetic patients with albuminuria

Cooper, M. E., Perkovic, V., Groop, P. H., Hocher, B., Hehnke, U., Meinicke, T., Koitka-Weber, A., van der Walt, S. & von Eynatten, M., 1 Jun 2019, In : Journal of Hypertension. 37, 6, p. 1294-1300 7 p.

Research output: Contribution to journalArticleResearchpeer-review

Open Access
File

Linagliptin and its effects on hyperglycaemia and albuminuria in patients with type 2 diabetes and renal dysfunction: The randomized MARLINA-T2D trial

Groop, P-H., Cooper, M. E., Perkovic, V., Hocher, B., Kanasaki, K., Haneda, M., Schernthaner, G., Sharma, S. K., Stanton, R. C., Toto, R., Cescutti, J., Gordat, M., Meinicke, T., Koitka-Weber, A., Thiemann, S. & Eynatten, M. V., Nov 2017, In : Diabetes, Obesity and Metabolism. 19, 11, p. 1610-1619 10 p.

Research output: Contribution to journalArticleResearchpeer-review

Open Access
File

Advances in the renin-angiotensin-aldosterone system: relevance to diabetic nephropathy.

Koitka-Weber, A. & Tikellis, C., 2008, In : The Scientific World Journal. 20, 8, p. 434-445 11 p.

Research output: Contribution to journalReview ArticleResearchpeer-review

Angiotensin Converting Enzyme 2 in the kidney.

Koitka-Weber, A., Cooper, M. E., Thomas, M. C. & Tikellis, C., 2008, In : Clinical and Experimental Pharmacology and Physiology. 35, 4, p. 420-425 5 p.

Research output: Contribution to journalReview ArticleResearchpeer-review